2/24
07:23 am
fhtx
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
2/24
07:00 am
fhtx
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Low
Report
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
2/23
07:00 am
fhtx
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
Low
Report
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
2/17
08:10 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc..
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc..
2/3
07:00 am
fhtx
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Low
Report
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
1/13
04:05 pm
fhtx
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Medium
Report
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
1/9
10:20 pm
fhtx
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
High
Report
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
12/20
01:30 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at
Wall Stre
High
Report
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at
Wall Stre
11/5/2025
07:00 am
FHTX
foghorn therapeutics inc.
BEAT
Report
16.3%
foghorn therapeutics inc.
5/14/2025
07:00 am
FHTX
foghorn therapeutics inc.
IN-LINE
Report
-3.3%
foghorn therapeutics inc.
2/24
04:03 pm
fhtx
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Low
Report
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
2/24
04:01 pm
fhtx
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Low
Report
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
2/23
07:00 am
fhtx
Form 8-K Foghorn Therapeutics For: Feb 23
Low
Report
Form 8-K Foghorn Therapeutics For: Feb 23
2/6
04:01 pm
fhtx
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Medium
Report
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
2/2
04:05 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
Low
Report
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
2/2
04:04 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: LaCascia Michael
Low
Report
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: LaCascia Michael
2/2
04:03 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Cardama Alfonso Quintas
Low
Report
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Cardama Alfonso Quintas
2/2
04:02 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Rivkin Anna
Low
Report
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Rivkin Anna
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register